The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones

Prostate

Volumn 69, Issue 16, 2009, Pages 1744-1750

  Baradaran, N ^a,a   Ahmadi, H ^a   Salem, S ^a   Lotfi, M ^b   Jahani, Y ^c   Mehrsai, A R ^a   Pourmand, G ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Iran; Prostate cancer; Sex hormones

Indexed keywords

ALBUMIN; ESTRADIOL; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; FAMILY HISTORY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS; GONADAL STEROID HORMONES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TIME FACTORS;

EID: 70350433657     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21023     Document Type: Article

References (37)

1. Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: A meta-analysis. Diabetologia 2004;47(6):1071-1078. (Pubitemid 38918167)
2. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995;273(20):1605-1609.
3. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15(11):2056-2062. (Pubitemid 44877026)
4. Tavani A, Gallus S, Bertuzzi M, Dal Maso L, Zucchetto A, Negri E, Franceschi S, Ramazzotti V, Montella M, La Vecchia C. Diabetes mellitus and the risk of prostate cancer in Italy. Eur Urol 2005;47(3):313-317; discussion 317. (Pubitemid 40124493)
5. Pitteloud N, Hardin M, Dwyer AA, Valassi E, YialamasM, Elahi D, Hayes FJ. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005;90(5):2636-2641. (Pubitemid 40686302)
6. Shaneyfelt T, Husein R, Bubley G, Mantzoros CS. Hormonal predictors of prostate cancer: A meta-analysis. J Clin Oncol 2000;18(4):847-853. (Pubitemid 30106616)
7. Hsing AW, Chua S Jr, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ. Prostate cancer risk and serum levels of insulin and leptin:Apopulation-based study. J Natl Cancer Inst 2001;93(10): 783-789. (Pubitemid 32514802)
8. Travis RC, Key TJ, Allen NE, Appleby PN, Roddam AW, Rinaldi S, Egevad L, Gann PH, Rohrmann S, Linseisen J, Pischon T, Boeing H, Johnsen NF, Tjonneland A, Overvad K, Kiemeney L, Bueno-de-Mesquita HB, Bingham S, Khaw KT, Tumino R, Sieri S, Vineis P, Palli D, Quiros JR, Ardanaz E, Chirlaque MD, LarranagaN, GonzalezC, Sanchez MJ, Trichopoulou A, Bikou C, Trichopoulos D, Stattin P, Jenab M, Ferrari P, Slimani N, Riboli E, Kaaks R. Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007;121(6):1331-1338. (Pubitemid 47293802)
9. Hsing AW, Reichardt JK, Stanczyk FZ. Hormones and prostate cancer: Current perspectives and future directions. Prostate 2002;52(3):213-235. (Pubitemid 34791223)
10. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005;161(2):147-152. (Pubitemid 40096789)
11. Will JC, Vinicor F, Calle EE. Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 1999; 10(3):313-318.
12. Zhu K, Lee IM, Sesso HD, Buring JE, Levine RS, Gaziano JM. History of diabetes mellitus and risk of prostate cancer in physicians. Am J Epidemiol 2004;159(10):978-982. (Pubitemid 38608275)
13. Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, Roshani A, Kheirollahi A, Kalantar E, Baradaran N, Saboury B, Allameh F, Karami A, Ahmadi H, Jahani Y. The risk factors of prostate cancer: A multicentric case-control study in Iran. Asian Pac J Cancer Prev 2007;8(3):422-428.
14. Pierce BL, Plymate S, Ostrander EA, Stanford JL. Diabetes mellitus and prostate cancer risk. Prostate 2008;68(10):1126-1132. (Pubitemid 351875184)
15. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2(5):307-314.
16. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 1998;9(1):3-9. (Pubitemid 28048654)
17. Tavani A, Gallus S, Bosetti C, Tzonou A, Lagiou P, Negri E, Trichopoulos D, La Vecchia C. Diabetes and the risk of prostate cancer. Eur J Cancer Prev 2002;11(2):125-128.
18. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R. Plasma insulinlike growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study. J Natl Cancer Inst 2000;92(23):1910-1917. (Pubitemid 32036921)
19. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 1998;279(5350):563-566. (Pubitemid 28067285)
20. Iwamura M, Sluss PM, Casamento JB, Cockett AT. Insulin-like growth factor I: Action and receptor characterization in human prostate cancer cell lines. Prostate 1993;22(3):243-252. (Pubitemid 23184735)
21. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37(6):1929-1933.
22. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88(16):1118-1126. (Pubitemid 26274606)
23. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2006;295(11):1288-1299.
24. Nair B, Wilt T, MacDonald R, Rutks I. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Cochrane Database Syst Rev 2002;1:CD003506.
25. Lucia MS, Bostwick DG, Bosland M, Cockett AT, Knapp DW, Leav I, Pollard M, Rinker-Schaeffer C, Shirai T, Watkins BA. Workgroup I: Rodent models of prostate cancer. Prostate 1998; 36(1):49-55.
26. MorgentalerA, TraishAM.Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth. Eur Urol 2009;55(2):310-320.
27. Eaton NE, Reeves GK, Appleby PN, Key TJ. Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies. Br J Cancer 1999;80(7):930-934.
28. Kaaks R, Lukanova A, Sommersberg B. Plasma androgens, IGF-1, body size, and prostate cancer risk: A synthetic review. Prostate Cancer Prostatic Dis 2000;3(3):157-172.
29. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004;108(3):418-424. (Pubitemid 37549608)
30. Kasper JS, Liu Y, Pollak MN, Rifai N, Giovannucci E. Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008;19(7):703-710.
31. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000;27:39-66.
32. Irani J, Ravery V, Pariente JL, Chartier-Kastler E, Lechevallier E, Soulie M, Chautard D, Coloby P, Fontaine E, Bladou F, Desgrandchamps F, Haillot O. Effect of nonsteroidal antiinflammatory agents and finasteride on prostate cancer risk. J Urol 2002;168(5):1985-1988.
33. Gonzalez-Perez A, Garcia Rodriguez LA. Prostate cancer risk among men with diabetes mellitus (Spain). Cancer Causes Control 2005;16(9):1055-1058. (Pubitemid 41356002)
34. Velicer CM, Dublin S, White E. Diabetes and the risk of prostate cancer: The role of diabetes treatment and complications. Prostate Cancer Prostatic Dis 2007;10(1):46-51. (Pubitemid 46358910)
35. Meyer P, Zuern C, Hermanns N, Haak T. The association between paternal prostate cancer and type 2 diabetes. J Carcinog 2007;6:14. (Pubitemid 350020760)
36. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991; 81(9):1158-1162.
37. Rothman KJ. modern epidemiology. Philadelphia: Lippincott Williams and Wilkins; 1998.